Clinical Trials in Arizona

Showing 2501-2520 of 8,032 trials

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

NCT04020185

Open-label, dose escalation (Phase I) and dose expansion (Phase IIA) study of patients receiving intra-tumoral IMSA101 alone or in combination with an immune checkpoint inhibitor (ICI) (Phase I and II)

Solid Tumor, Adult

ImmuneSensor Therapeutics Inc.40 participantsStarted Sep 2019

Scottsdale, Arizona, United States • La Jolla, California, United States • Chicago, Illinois, United States +3 more locations

COMPLETEDPhase 231 miles

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

NCT04985916

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

Lateral Canthal Lines, LCLCrow's Feet

Eirion Therapeutics Inc.280 participantsStarted Jul 2021

Scottsdale, Arizona, United States • San Diego, California, United States • Aventura, Florida, United States +16 more locations

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Find Trials by Condition in Arizona

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Osia 2 Pediatric Expansion Study

Electrophysiological Recordings from Deep Brain Stimulation Electrodes for Pain

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Study of ATH434 in Participants with Multiple System Atrophy

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria